Chemical and biological investigation of N-hydroxy-valdecoxib: An active metabolite of valdecoxib

The inhibition of cyclooxygenase enzymes plays an important role in the treatment of inflammatory diseases. N-Hydroxy-4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide ( 3)—a primary metabolite of the highly selective COX-2 inhibitor valdecoxib—was synthesized and stabilized as its monohydrate (...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry Vol. 16; no. 9; pp. 5322 - 5330
Main Authors Erdélyi, Péter, Fodor, Tamás, Varga, Ágnes Kis, Czugler, Mátyás, Gere, Anikó, Fischer, János
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 01.05.2008
Elsevier Science
Subjects
Rat
Online AccessGet full text

Cover

Loading…
More Information
Summary:The inhibition of cyclooxygenase enzymes plays an important role in the treatment of inflammatory diseases. N-Hydroxy-4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide ( 3)—a primary metabolite of the highly selective COX-2 inhibitor valdecoxib—was synthesized and stabilized as its monohydrate ( 3a·H 2O). The anti-inflammatory properties of 3a·H 2O were investigated in carrageenan-induced edema and in acute and chronic pain models. Based on our biological investigation, we conclude that N-hydroxy-valdecoxib 3a is an active metabolite of valdecoxib.
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2008.02.088